Market Analysis
Trump’s CBD Pivot: Which Cannabis Stocks Could Win Big?
Trump’s embrace of CBD could mark a turning point for U.S. cannabis policy and investors are already betting on the winners.
BTC$62,618.00-0.25%
ETH$1,784.25+0.38%
USDT$0.9988-0.04%
USDC$0.9999+0.01%
XRP$1.07-0.61%
SOL$75.19-1.62%
TRX$0.3249-1.59%
FIGR_HELOC$1.03+1.91%
HYPE$63.74-2.41%
DOGE$0.0723+0.10%
USDS$0.99970.00%
RAIN$0.0143-0.35%
LEO$9.54+0.05%
ZEC$507.59-1.85%
WBT$54.95-0.04%
BTC$62,618.00-0.25%
ETH$1,784.25+0.38%
USDT$0.9988-0.04%
USDC$0.9999+0.01%
XRP$1.07-0.61%
SOL$75.19-1.62%
TRX$0.3249-1.59%
FIGR_HELOC$1.03+1.91%
HYPE$63.74-2.41%
DOGE$0.0723+0.10%
USDS$0.99970.00%
RAIN$0.0143-0.35%
LEO$9.54+0.05%
ZEC$507.59-1.85%
WBT$54.95-0.04%
Tilray Brands stock jumped more than 27% in premarket trading after Redecan launched a new premium vape product line.
Trump’s embrace of CBD could mark a turning point for U.S. cannabis policy and investors are already betting on the winners.
Republican-led legalization effort gains traction, leading to a potential increase in the value of cannabis stocks.
Although risky, these cannabis companies stand on solid ground